LARP7P2

Across TCGA pan-cancer cohorts, LARP7P2 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated LARP7P2 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher LARP7P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LARP7P2 expression acts as an unfavorable survival marker, although some lineages such as ESCA and LAML show a favorable association.

UVM, THCA, and ESCA are the cancer types where LARP7P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	All	0.363	0.759	.011	27	view →
THCA	DFS	Quartile	IV	0.255	0.931	.001	22	view →
ESCA	DFS	Median	II,III,IV	0.447	0.234	.007	20	view →
ACC	OS	Tertile	IV	0.327	0.633	.045	18	view →
LIHC	OS	Tertile	All	0.266	0.683	.004	18	view →
PAAD	OS	Tertile	All	0.200	0.421	.002	17	view →
STAD	OS	Median	II,III,IV	0.436	0.658	.027	10	view →
DLBC	OS	Tertile	II,III,IV	0.118	0.802	.025	9	view →
KIRP	OS	Tertile	IV	0.033	0.394	.034	9	view →
LUSC	OS	Tertile	II,III,IV	0.624	0.752	.035	9	view →
LAML	DFS	Median	All	0.671	0.481	.024	6	view →
CHOL	DFS	Quartile	All	0.756	0.337	.040	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

LARP7P2–UVM (OS)

Open the UVM breakdown →